Tag: cel-sci

October 21, 2016

CEL-SCI Provides Update on Partial Clinical Hold on Phase 3 Clinical Trial

CEL-SCI has started working on a response to the FDA and will work diligently with the FDA to seek to...
September 27, 2016

CEL-SCI Reports Clinical Hold on Head and Neck Cancer Study

CEL-SCI Corporation announced today that it has received verbal notice from the U.S. Food and Drug Administration that its Multikine...
September 2, 2016

CEL-SCI Reports Monthly Patient Enrollment in August for Its Phase 3 Head and Neck Cancer Trial

VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE MKT: CVM) (“CEL SCI” or the “Company”) today announced that during the month of August...